Skip to main content
. 2023 Jan 9;15:1025066. doi: 10.3389/fnmol.2022.1025066

Figure 10.

Figure 10

The evodiamine derivative 4c improves AD pathology via the PI3K/AKT/GSK3β pathway. Compound 4c reversed the impairment of the PI3K/AKT/GSK3β signaling pathway in AD mice, thereby improving AD pathology (diagram was created with BioRender.com).